Skip to main content
ORIC
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
4
Price
$9.72
Mkt Cap
$968.457M
52W Low
$4.52
52W High
$14.93
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, ORIC was trading at $9.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $968.5M. The 52-week trading range was $4.52 to $14.93. This filing was assessed with an importance score of 4 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ORIC - Latest Insights

ORIC
Apr 28, 2026, 4:03 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Shareholders to Vote on Amended Equity Plan with Significant Annual Evergreen Provision and High Overhang
Sentiment: Negative
View Wiseek Article
ORIC
Mar 31, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Oric Pharmaceuticals Selects Phase 3 Dose for Rinzimetostat, Plans Pivotal Trial in Prostate Cancer
Sentiment: Positive
View Wiseek Article
ORIC
Feb 23, 2026, 5:06 PM EST
Filing Type: 8-K
Importance Score:
8
Oric Pharmaceuticals Replaces ATM Program with New $200M Offering, Discloses $139.7M Already Sold
Sentiment: Neutral
View Wiseek Article
ORIC
Feb 23, 2026, 5:02 PM EST
Filing Type: 424B5
Importance Score:
8
Oric Pharmaceuticals Expands At-The-Market Offering to $200M, Potentially Diluting Shares by 18%
Sentiment: Negative
View Wiseek Article
ORIC
Feb 23, 2026, 4:15 PM EST
Filing Type: 10-K
Importance Score:
7
Oric Pharma Reports Strong Phase 1b Data for Two Lead Oncology Candidates, Extends Cash Runway into H2 2028
Sentiment: Neutral
View Wiseek Article
ORIC
Feb 23, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
ORIC Pharmaceuticals Reports Strong Clinical Data, Extended Cash Runway into 2H 2028, and Upcoming Phase 3 Trial
Sentiment: Positive
View Wiseek Article